In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific researchers, including at MIT, have turned to artificial intelligence, and to quantitative analysis and modeling, to design and construct engineered cells with novel properties. The engineered cells can be programmed to become new therapeutics ' battling, and perhaps eradicating, diseases. James J. Collins is one of the founders of the field of synthetic biology, and is also a leading researcher in systems biology, the interdisciplinary approach that uses mathematical analysis and modeling of complex systems to better understand biological systems. His research has led to the development of new classes of diagnostics and therapeutics, including in the detection and treatment of pathogens like Ebola, Zika, SARS-CoV-2, and antibiotic-resistant bacteria. Collins, the Termeer Professor of Medical Engineering and Science and professor of biological engineering at...
learn more
